Guidelines for the management of aSAH Risk Factors for and Prevention
|
Subarachnoid Hemorrhage Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012)
|
|
Case Studies |
|
Guidelines for the management of aSAH Risk Factors for and Prevention On the Web |
|
American Roentgen Ray Society Images of Guidelines for the management of aSAH Risk Factors for and Prevention |
|
FDA on Guidelines for the management of aSAH Risk Factors for and Prevention |
|
CDC on Guidelines for the management of aSAH Risk Factors for and Prevention |
|
Guidelines for the management of aSAH Risk Factors for and Prevention in the news |
|
Blogs on Guidelines for the management of aSAH Risk Factors for and Prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Mehrsefat, M.D. [2]
2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage[1]
Risk Factors for and Prevention of aSAH: Recommendations
| Class I |
| "1. Treatment of high blood pressure with antihypertensive medication is recommended to prevent ischemic stroke, intracerebral hemorrhage, and cardiac, renal, and other end-organ injury (Level of Evidence: A)" |
| "2. Hypertension should be treated, and such treatment may reduce the risk of aSAH (Level of Evidence: B)" |
| "3. Tobacco use and alcohol misuse should be avoided to reduce the risk of aSAH (Level of Evidence: B)" |
| "4. After any aneurysm repair, immediate cerebrovascular imaging is generally recommended to identify remnants or recurrence of the aneurysm that may require treatment (Level of Evidence: B)" |
| Class IIb |
| "1. In addition to the size and location of the aneurysm and the patient’s age and health status, it might be reasonable to consider morphological and hemody- namic characteristics of the aneurysm when discuss- ing the risk of aneurysm rupture (Level of Evidence: B)" |
| "2. Consumption of a diet rich in vegetables may lower the risk of aSAH (Level of Evidence: B)" |
| "3. It may be reasonable to offer noninvasive screening to patients with familial (at least 1 first-degree relative) aSAH and/or a history of aSAH to evaluate for de novo aneurysms or late regrowth of a treated aneurysm, but the risks and benefits of this screening require further study (Level of Evidence: B)" |
References
- ↑ Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage http://stroke.ahajournals.org/content/early/2012/05/03/STR.0b013e3182587839